Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Unique Case of Type 3 Von Willebrand Disease

Mamatha Mandava, MD, John Lazarchick, MD, Emily Curl, Shayla Bergmann, MD

Blood (2018) 132 (Supplement 1): 5031.

https://doi.org/10.1182/blood-2018-99-112976

Published: 2018

Journal Articles

Characterization of Mast Cell Activation Syndrome

Lawrence B Afrin, MD, Sally Self, MD, Jeremiah Menk, M.S., John Lazarchick, MD

Blood (2016) 128 (22): 3683.

https://doi.org/10.1182/blood.V128.22.3683.3683

Published: 2016

Journal Articles

Type 3 Von Willebrand Disease: A Case Report of a Rare Entity

Stephanie Phillips, DO, John Lazarchick, MD, Shayla Bergmann, MD

Blood (2016) 128 (22): 4988.

https://doi.org/10.1182/blood.V128.22.4988.4988

Published: 2016

Journal Articles

Analyzing the Impact of Implementing a Systems-Based Hematologist into the Healthcare Delivery System at an Academic Medical Center

Charles S Greenberg, MD, Caroline Dupre Vaughn, RN, Alice Boylan, MD, Jerry E Squires, MDPhD, Sharon DeGrace, RN,MN, John Lazarchick, MD, Adrian Reuben, MBBS,FRCP,FACG, Alan C. Finley, MD, Joseph Mazur, PharmD,BCPS,BCNSP

Blood (2015) 126 (23): 4467.

https://doi.org/10.1182/blood.V126.23.4467.4467

Published: 2015

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

Implementation of a Heparin-Induced Thrombocytopenia Management Program Reduces the Cost of Diagnostic Testing and Pharmacologic Treatment in an Academic Medical Center

Caroline Dupre Vaughn, RN, Joseph Mazur, PharmD, Joyce Foster, MHS,MT(ASCP), John Lazarchick, MD, Alice Boylan, MD, Charles S Greenberg, MD

Blood (2014) 124 (21): 4848.

https://doi.org/10.1182/blood.V124.21.4848.4848

Published: 2014

Journal Articles

Factor VII Deficiency In African American Individuals. Presentation, Diagnosis and Management.A Single Medical Center Experience

Tabitha Nicole Townsend, MD, John Lazarchick, MD, Charles S Greenberg, MD, Jenny H. Petkova, MD

Blood (2013) 122 (21): 4779.

https://doi.org/10.1182/blood.V122.21.4779.4779

Published: 2013

Journal Articles

Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis

Linsheng Zhang, MB, PhD, Sally E. Self, MD, John Lazarchick, MD

Blood (2010) 116 (21): 1903.

https://doi.org/10.1182/blood.V116.21.1903.1903

Published: 2010

Journal Articles

Adult Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Follow-Up in a Consecutive Series of Ten Patients.

Keisuke Shirai, MD, Alberto Montero, MD, Jesse Powell, MD, Lydia Christiansen, MD, John Lazarchick, MD

Blood (2006) 108 (11): 3845.

https://doi.org/10.1182/blood.V108.11.3845.3845

Published: 2006

Journal Articles

Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations

Thomas L. Ortel, Karen D. Moore, Mary Ann Quinn-Allen, Takashi Okamura, Allen J. Sinclair, John Lazarchick, Ramaswamy Govindan, Françoise Carmagnol, William H. Kane

Blood (1998) 91 (11): 4188–4196.

https://doi.org/10.1182/blood.V91.11.4188

Published: 1998

NARROW

A Unique Case of Type 3 Von Willebrand Disease

Characterization of Mast Cell Activation Syndrome

Type 3 Von Willebrand Disease: A Case Report of a Rare Entity

Analyzing the Impact of Implementing a Systems-Based Hematologist into the Healthcare Delivery System at an Academic Medical Center

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Implementation of a Heparin-Induced Thrombocytopenia Management Program Reduces the Cost of Diagnostic Testing and Pharmacologic Treatment in an Academic Medical Center

Factor VII Deficiency In African American Individuals. Presentation, Diagnosis and Management.A Single Medical Center Experience

Detection of Minimal Residual Disease of Plasma Cell Myeloma by Five Color Flow Cytometric Immunophenotype Analysis

Adult Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Follow-Up in a Consecutive Series of Ten Patients.

Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only